P. Meldgaard et al., BLOOD-GROUP ABO-RELATED GLYCOSYLATION OF UROTHELIAL CELL-LINES - IMMUNOCYTOLOGICAL, ENZYMATIC, AND GENETIC-CHARACTERIZATION, Cancer research, 54(9), 1994, pp. 2440-2447
Three immortalized, human urothelial cell lines were characterized wit
h respect to their ABO-related carbohydrate phenotypes using a panel o
f monoclonal antibodies directed to a series of carbohydrate epitopes
(Lac, sialylated Lac, Le(a), sialylated Le(a), Le(x), sialylated Le(x)
, H types I and II, Le(y), Le(b), A monofucosylated types I and II, AL
e(y), ALe(b), and A type III). The glycosyltransferases forming some o
f these epitopes (beta 1-3/4 galactosyltransferase, alpha 1-2 fucosylt
ransferase, alpha 1-3 galactosyltransferase, and alpha 1-3-N-acetyl-ga
lactosaminyltransferase) were determined by enzyme assays. The ABO gen
e complex was analyzed by Southern blotting, Northern blotting, and po
lymerase chain reaction across the O deletion and across base differen
ces between the A and B alleles. The immunocytochemical stainings show
ed marked differences between the three cell lines; the high grade (tu
morigenic, metastatic) cell line showed difucosylated types I and II s
tructures, and the low grade (nontumorigenic, nonmetastatic) cell line
s showed monofucosylated types I and II structures. Polymerase chain r
eaction genotyping of the cell lines indicated that one was OO, one wa
s AA, and one was A plus a mutated allele. Northern blotting showed RN
A encoding the A transferase. However, even though both of the A cell
lines seemed to have an intact gene, which could produce A transferase
and transcibed RNA, none of them showed any activity of the A gene en
coded enzyme or any A-structures at the cell surface. In contrast, the
three other examined glycosyltransferases were active. The three urot
helial cell lines reflect in vivo findings in humans. They represent a
competent system for in vitro studies of the different carbohydrate t
ransferase genes responsible for the carbohydrate structures expressed
on the cell surface in bladder tumors.